IU Simon Comprehensive Cancer Center Showcases Eight Abstracts and Posters at AACI 2026
Source
OncoDailyIU Simon Comprehensive Cancer Center Showcases Eight Abstracts and Posters at AACI 2026oncodaily.comYou might also wanna read
CU Anschutz Clinical Trial Tests Orforglipron, an Oral GLP-1 Pill as Alternative to Injectable Weight-Loss Drugs
Orforglipron is an FDA-approved non-peptide oral GLP-1 pill being studied as an alternative to injectable weight-loss drugs like Ozempic and
news.cuanschutz.edu·16h ago
Nanoplatform co-delivering H2S and Ni2+ reverses chemoresistance and enhances immunotherapy in breast cancer
This research article presents a study on a novel nanoplatform (NiS@ALB) designed to combat chemoresistance in breast cancer. The authors de
Phase 1 trial finds triple monoclonal antibody combination safe and effective for HIV-1 prevention
This phase 1, multicentre, randomised, open-label trial (HVTN 140/HPTN 101 part B) evaluated the safety, pharmacokinetics, and neutralisatio
PARTNERS trial begins enrolling patients in DRC to test treatments for Bundibugyo virus disease
The PARTNERS clinical trial has begun enrolling patients in the Democratic Republic of the Congo to evaluate potential treatments for Bundib
who.int·5d agoPARTNERS trial begins enrolling patients in DRC to test treatments for Bundibugyo virus disease
The PARTNERS clinical trial has begun enrolling patients in the Democratic Republic of the Congo to evaluate potential treatments for Bundib
who.int·5d ago
Study reveals how immunotherapy can drive immune evasion in pancreatic cancer through Treg cell activity and MHC-I suppression
This study investigates mechanisms driving immunotherapy resistance in pancreatic ductal adenocarcinoma (PDA). Using murine models, the rese
scim.ag·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.